What question did this study set out to answer?

To analyze the incidence of postinflammatory hyperpigmentation following carbon dioxide laser therapy, evaluate associated risk factors, and determine the efficacy of preventive interventions.

May 19, 2023Dermatology ReportsOpen Access

Postinflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

View Full Paper

Ask AI

Bookmark

Authors

ADAlhanouf Bin DakhilImam Mohammad ibn Saud Islamic University ASAsem ShadidSulaiman Al Rajhi Colleges SASaad AltalhabImam Mohammad ibn Saud Islamic University

Discussion

Member takes

Implication

Systematic review reveals topical anti-inflammatory agents reduce postinflammatory hyperpigmentation after carbon dioxide laser therapy, suggesting inflammation control mitigates pigmentary risks.

Key Points

To analyze the incidence of postinflammatory hyperpigmentation following carbon dioxide laser therapy, evaluate associated risk factors, and determine the efficacy of preventive interventions.
Systematic search of PubMed and Embase databases identifying 211 citations and including 14 relevant clinical studies.
Extracted and compared data across patient demographics (N=313; 70% female, 30% male; mean age 30 years; 59% Fitzpatrick type IV, 25% type III) and preventive modalities.
Across eight preventive trials, topical clobetasol propionate 0.05% and fusidic acid cream achieved postinflammatory hyperpigmentation incidence rates of 39% and 53.3%, respectively.
Postinflammatory hyperpigmentation risk was not significantly influenced by Fitzpatrick skin phototype across the analyzed trials.

Cite This Study

Dakhil et al. (2023) studied this question.

synapsesocial.com/papers/6a9fc542516c2ec66e7c67ee https://doi.org/10.4081/dr.2023.9703

View Full Paper

Ask AI

Bookmark

May 19, 2023Dermatology ReportsOpen Access

Postinflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

View Full Paper

Ask AI

Bookmark

Authors

ADAlhanouf Bin DakhilImam Mohammad ibn Saud Islamic University ASAsem ShadidSulaiman Al Rajhi Colleges SASaad AltalhabImam Mohammad ibn Saud Islamic University

Discussion

Member takes

Implication

Systematic review reveals topical anti-inflammatory agents reduce postinflammatory hyperpigmentation after carbon dioxide laser therapy, suggesting inflammation control mitigates pigmentary risks.

Key Points

To analyze the incidence of postinflammatory hyperpigmentation following carbon dioxide laser therapy, evaluate associated risk factors, and determine the efficacy of preventive interventions.
Systematic search of PubMed and Embase databases identifying 211 citations and including 14 relevant clinical studies.
Extracted and compared data across patient demographics (N=313; 70% female, 30% male; mean age 30 years; 59% Fitzpatrick type IV, 25% type III) and preventive modalities.
Across eight preventive trials, topical clobetasol propionate 0.05% and fusidic acid cream achieved postinflammatory hyperpigmentation incidence rates of 39% and 53.3%, respectively.
Postinflammatory hyperpigmentation risk was not significantly influenced by Fitzpatrick skin phototype across the analyzed trials.

Cite This Study

Dakhil et al. (2023) studied this question.

synapsesocial.com/papers/6a9fc542516c2ec66e7c67ee https://doi.org/10.4081/dr.2023.9703

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark